Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
2-[[(1R,2S)-2-Aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-5-pyrimidinecarboxamide hydrochloride acts as a novel spleen tyrosine kinase (syk) inhibitors used in the treatment of leukemia.